2015/2016 Quality Risk Management Benchmarking Survey

Reference

1. 1.↵
   Parenteral Drug Association (PDA). Technical Report Number 54, Implementation of Quality Risk Management for Pharmaceutical and Biopharmaceutical Manufacturing Operations. 2012.
2. 2.↵
   International Council on Harmonization (ICH). Guideline Q9, Quality Risk Management. June 2005.
3. 3.↵
   1. Waldron K.,
   2. Ramnarine E.,
   3. Hartman J.

   Regulation Snapshot: PDA and Dublin Tech Institute to Collaborate on QRM. PDA Letter 2015, October.
4. 4.↵
   1. Ahmed R.,
   2. Baseman H.,
   3. Gerreira J.,
   4. Genova T.,
   5. Harclerode W.,
   6. Hartman J.,
   7. Kim S.,
   8. Londeree N.,
   9. Long M.,
   10. Miele W.,
   11. Ramjit T.,
   12. Raschiatore M.,
   13. Tomonto C.

   , PDA's Risk Management Task Force. PDA Survey of Quality Risk Management Practices in the Pharmaceutical, Devices, & Biotechnology Industries. PDA J. Pharm. Sci. Technol. 2008, 62(1), 1–21.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Waldron K.,
   2. Greene A.,
   3. Calnan N.

   Quality Risk Management: State of the Industry. Part 1—Has Industry Realized the Full Value of QRM? Journal of Validation Technology 2015, January.
6. 6.↵
   1. O'Donnell K.

   QRM in the GMP Environment: Ten Years On—Are Medicines Any Safer Now? A Regulators Perspective. Journal of Validation Technology 2015, December.